High prevalence of rheumatoid factor in community-based series of patients with rheumatoid arthritis meeting the new (1987) ARA criteria: RF- negative non-erosive rheumatoid arthritis is very rare

Scandinavian Journal of Rheumatology

Volumn 27, Issue 5, 1998, Pages 368-372

  Hakala, Markku ^a   Sajanti, Esko ^a   Ikäheimo, Irma ^a   Aho, Kimmo ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

HLA DRB1 oligotyping; MHC Class II; Population; Rheumatoid factor; Seronegative rheumatoid arthritis

Indexed keywords

HLA DR ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RHEUMATOID FACTOR;

ADULT; ARTHRITIS; ARTICLE; FEMALE; FINLAND; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEROPREVALENCE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREVALENCE; RHEUMATOID FACTOR;

EID: 0031724949     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749850154401     Document Type: Article

References (25)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Masi AT, Feigenbaum SL. Seronegative rheumatoid arthritis: fact or fiction ? Arch Intern Med 1983;143:2167-72.
3. Lichtenstein MJ, Pincus T. Rheumatoid arthritis identified in population based cross sectional studies: low prevalence of rheumatoid factor. J Rheumatol 1991;18:989-93.
4. Pincus T, Callahan LF. How many types of patients meet classification criteria for rheumatoid arthritis? J Rheumatol 1994;21:1385-9.
5. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
6. Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674-8.
7. Hakala M, Nieminen P, Koivisto O. More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 1994;21:1432-7.
8. Hakala M, Nieminen P. Functional status assessment of physical impairment in a community based population with rheumatoid arthritis: Severely incapacitated patients are rare. J Rheumatol 1996;23:617-23.
9. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977;18:481-91.
10. Melamies LM, Ruutsalo HM, Nissilä M. Evaluation of a quantitative immunoturbidimetric assay for rheumatoid factors: Clin Chem 1986;32:1890-4.
11. BMDP Statistical Software Inc. SOLO user's guide. Version 2.0, 1988:1-266.
12. BMDP Statistical Software. SOLO advanced set. Version 2.0, 1988:1-92.
13. Nykänen M, Palosuo T, Aho K. Sahi T, von Essen R. Improved immunoturbidimetric method for rheumatoid factor testing. J Clin Pathol 1993;46:1065-6.
14. Aho K, Heliövaara M, Sievers K, Maatela M, Isomäki H. Clinical arthritis associated with positive radiological and serological findings in Finnish adults. Rheumatol Int 1989;9:7-11.
15. Wolfe F. 50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis. J Rheumatol 1990;17 Suppl 22:24-32.
16. Simonsson M, Bergman S, Jacobsson L, Petersson L, Svensson B. The prevalence of rheumatoid arthritis in Sweden an epidemiological study. Scand J Rheumatol 1997;26:139.
17. Mikkelsen WM, Dodge H. A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Mitchigan, Community Health Study. Arthritis Rheum 1969;12:87-91.
18. O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis: follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 1972;76:573-7.
19. Gran JT, Hushy G. Seronegative rheumatoid arthritis and HLA-DR4: proposal for criteria. J Rheumatol 1987;14:1079-82.
20. Calin A, Marks SH. The case against seronegative rheumatoid arthritis. Am J Med 1981;70:992-4.
21. Kaarela K, Alekherova Z, Lehtinen K, Puolakka K, Koskimies S, Nassonova V, et al. Seronegative rheumatoid arthritis: a clinical study with HLA typing. J Rheumatol 1990;17:1125-9.
22. Buchanan WW, Singal DP. Seronegative rheumatoid arthritis: Tell it as it is. J Rheumatol 1994;21:391-3.
23. Vehe RK, Nepom GT, Wilske KR, Stage D, Begovich AB, Nepom BS. Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar. J Rheumatol 1994;21:194-6.
24. Aho K, Julkunen H, Laine V, Ripatti N, Wager O. Clinical evaluation of the serological tests in rheumatoid arthritis. I. Normal series collected by random sampling. Acta Rheumatol Scand 1961;7:201-8.
25. Hakala M, Silvennoinen-Kassinen S, Ikäheimo I, Isosomppi J, Tiilikainen A. HLA markers in a community based rheumatoid arthritis series. Ann Med 1997;29:291-6.